Patti White, Chief Executive Officer


Patti White’s career has focused on finding and building solutions that make a difference in people's lives.  She started out as a pioneer in personal computers and then moved to medical where she has commercialized medical technology, established global distribution channels, created strategic partnerships, and built new companies. 

Patti co-founded Inovise Medical and served as its CEO from 1997 to 2009. Inovise Medical is the recognized world leader in heart sound technology used for both diagnosis and treatment assessment.  Inovise also created and licensed superior ECG algorithms and invented a low cost patient monitor for developing countries that had high impact and was a commercial success.  As CEO, Patti raised over $70 million in grant, angel, venture and corporate funding. Patti also served as Chief Commercial Officer of Brien Holden Vision Diagnostics, a social enterprise start-up focused on vision diagnostics for developing countries.  Previously, Patti was the VP and General Manager at RS Medical where she developed partnerships in pain trays, ultrasound, platelet rich plasma, and RF neurotomy and launched these products using the largest US pain medicine sales force. Patti’s earlier background includes a 13-year career at Hewlett Packard in marketing, R&D, and international management in medical and personal computers. Patti has an MBA from The Wharton School at the University of Pennsylvania and a BA in finance and international business from the University of Washington.


Peter Galen has worked in medical device companies for 30 years and released more than 50 products. He has worked as an engineer, project manager, director, VP and CEO. His experience working at all levels in the business enables him to understand the details, as well as the “big picture,” which results in successful solutions and high quality product launches.

Peter has had two successful company exits, the most recent a company focused on preventing blindness, Quantum Catch Corp. which he sold to the world’s largest optometry research group. He also co-founded CardioDigital, Inc., where he led the sale to Covidien/Medtronic.

Peter’s experience in product development and manufacturing in Asia began in the late 80s, and included setting up Welch Allyn’s R & D affiliate in Singapore for emerging companies. He also managed Hewlett Packard’s diagnostic cardiology R&D. Peter has 17 patents issued and 15 more that are pending. He serves on several boards and helps four universities with their translational activities. He has a BS in biomedical engineering from Case Western Reserve University and an MS in electrical engineering with a biomedical focus from the University of Washington.

Daren bledsoe, vice president engineering

Daren Bledsoe, Vice President Engineering: Daren has been an R&D development engineer, manufacturing engineer, project manager, program manager, marketing manager, director and AVP of Engineering. He has worked in medical device and semiconductor industries for over 30 years and released more than 30 products. While at Hewlett Packard's Diagnostic Cardiology Division, he led the development and product release of HP’s first transport defibrillator while cutting the end-to-end cycle by 50%. His semiconductor management experience includes more than 20 complex SOC devices, 8 platform solutions and associated firmware. Daren has had management responsibility for R&D organizations in US, Malaysia and China. His broad cross-functional experience, interpersonal skills and in depth understanding in how to set up and run complex programs using both internal resources and external partners has resulted in the successful on-time release of both medical products and complex System-on-a-Chip silicon solutions. Daren has been named as an inventor in over 40 issued patents. He earned his BS in Electrical Engineering from Washington State University.

brian grimberg, phd, CHief Scientist, Malaria

Brian Grimberg.jpg

Brian Grimberg, PhD, Chief Scientist, Malaria, is an Assistant Professor of International Health, Infectious Disease and Immunology at CWRU School of Medicine, one of the country's leading global health universities. Dr. Grimberg's diverse tropical disease research portfolio takes him around the globe in pursuit of drug discovery, vaccine development, and disease eradication.  He teaches about infectious diseases at the CWRU School of Medicine, and has given global health talks in 10 countries. He has worked in the field of malaria for 12 years, and in 2011 invented the original technology behind MOD. Dr. Grimberg has received grant awards supporting his global health work in multiple countries and the development of MOD malaria diagnostic technology.

Umut Gurkan, PHD, Chief Scientist, Microfabrication

Umut Gurkan, PhD, Chief Scientist, Sickle Cell Disease, holds a PhD degree in Biomedical Engineering from Purdue University. He completed his postdoctoral training in medicine at Brigham and Women’s Hospital, Harvard Medical School and Harvard-MIT Health Sciences and Technology after which he joined CWRU as Assistant Professor. Dr. Gurkan is leading the CASE Biomanufacturing and Microfabrication Laboratory (CASE-BML). The inventor, Dr. Gurkan has received numerous national and international recognitions and awards for developing translational POC technologies that have been clinically tested both in the developing countries and in the developed world. Dr. Gurkan will be leading field teams, recruiting patients, coordinating IRB approval, data security, and aiding in sample analysis both in the field and in the US. He has 46+ publications and 6+ national/international patent applications, and 1 issued international patent on POC testing. He co-founded a start-up company while in graduate school, and submitted numerous SBIR and STTR applications.


poornima 2.jpg

Poornima Kumar,Managing Director of the Hemex Health subsidiary in India, holds an M.Sc. in  Biological Sciences from the University of Kerala, India and a post graduate certificate in biotechnology from Cal State Hayward.  She has worked in the Biotech Industry in the Bay Area since 1990. She started her career as a researcher in Genelabs Technologies, working on drug development and later moved into the diagnostic area managing a line of diagnostic products for HIV, TB and Hepatitis.  She worked in International sales and marketing of diagnostic products and has several years of experience working in India, Africa and South East Asia. Later, she worked in clinical research working for Idexx Laboratories and built up their GLP pre-clinical business.  From early 2000 on, she worked as Director of Business Development for large CROs which conducted Phase I, II and III clinical trials globally.